Hip replacement surgery is not automatically ruled out by a diagnosis of heart failure, but it does carry meaningfully higher risks. People with heart failure who undergo total hip arthroplasty face roughly double the adjusted risk of 30-day death compared to those without heart failure, along with greater odds of complications ranging from blood clots to kidney injury. The surgery still happens regularly, though, because the alternative for many patients is worsening immobility that itself strains the heart. The real question is less whether it can be done and more how the risks can be managed and who is most likely to benefit.
How Much Higher Are the Risks?
The numbers vary by study design and time horizon, but the overall pattern is consistent: heart failure raises the stakes across nearly every complication category. One large analysis found that heart failure patients undergoing total hip arthroplasty had roughly three and a half times the odds of dying, more than eight times the odds of cardiac arrest, and about three and a half times the odds of heart attack compared to matched patients without heart failure. Hospital stays ran longer, and patients were far less likely to go home directly after surgery rather than to a rehabilitation facility or nursing home.
A separate study using propensity-matched data confirmed higher 90-day rates of pulmonary embolism, deep vein thrombosis, pneumonia, stroke, heart attack, sepsis, kidney failure, and urinary tract infection in the heart failure group. The complications extended past the immediate recovery window: at one year, heart failure patients also showed higher rates of prosthetic joint infection, loosening of the implant, and dislocation, along with greater emergency department visits and readmissions.
These aren’t small differences buried in statistical noise. They represent a real shift in the risk-benefit conversation. But the risks need context. A younger patient with well-controlled, mild heart failure is in a very different position than an 85-year-old with advanced disease and multiple other conditions. Risk is not binary, and neither is the surgical decision.
Elective Versus Emergency Surgery
One of the biggest factors in how a heart failure patient fares after hip surgery is whether the operation is planned or urgent. A study tracking heart failure patients across both elective and emergency orthopedic procedures found dramatic differences. After elective surgery, 30-day mortality for heart failure patients was about 3.2%, rising to 6.5% at 90 days and 16.2% at one year. After emergency surgery, those figures jumped to 13.7% at 30 days, 22.4% at 90 days, and 39.3% at one year.
Even after adjusting for other health differences, heart failure more than doubled the risk of 30-day death following elective orthopedic surgery. For emergency procedures, the adjusted risk was still about 50% higher.
The practical takeaway is important: if you have heart failure and a deteriorating hip, there’s an argument for addressing it electively rather than waiting until you fall and need emergency surgery. A planned hip replacement allows time for cardiac optimization, careful anesthesia planning, and assembling the right surgical team. A hip fracture in the middle of the night does not. This is a point your orthopedic surgeon and cardiologist should discuss together, because the window for elective intervention does close if hip arthritis becomes severe enough to cause falls.
Does the Type of Heart Failure Change the Odds?
Heart failure comes in different varieties, and clinicians increasingly want to know whether the type matters for surgical risk. The two main categories are heart failure with reduced ejection fraction, where the heart pumps less forcefully than normal, and heart failure with preserved ejection fraction, where the heart pumps adequately but doesn’t relax and fill properly. Both are dangerous, but the risk profiles differ somewhat.
A matched-pair study comparing these two groups among hip replacement patients found that reduced ejection fraction carried higher odds of kidney failure, heart attack, stroke, atrial fibrillation, and death within a year after surgery. Cardiac arrest and sepsis rates did not differ significantly between the two types.
Another study focusing on hip fracture surgery found that both types of heart failure raised the odds of major adverse cardiac and cerebrovascular events by similar amounts, roughly 70-75% higher than patients without heart failure. The reduced-ejection-fraction group had a slightly higher adjusted odds ratio, but both groups were clearly at elevated risk.
From a practical standpoint, this means that having heart failure with preserved ejection fraction is not the reassuring distinction some patients hope for. Both types warrant the same level of preoperative cardiac workup and perioperative vigilance. If anything, preserved-ejection-fraction heart failure may be underestimated by some surgical teams because the heart’s pumping numbers look normal on an echocardiogram, masking the underlying problem with how the heart fills and handles fluid shifts during surgery.
Preoperative Testing That Helps Guide the Decision
For heart failure patients considering hip replacement, the preoperative workup is more involved than the standard clearance visit. Beyond a recent echocardiogram and a review of current medications, one of the more useful tools is a blood test for B-type natriuretic peptide, or BNP. This protein rises when the heart is under strain, and multiple studies have found it to be a strong predictor of who will run into trouble after orthopedic surgery.
In one study of orthopedic surgery patients, preoperative BNP was the strongest independent predictor of postoperative cardiac events, outperforming age and the standard anesthesia risk scoring system. Using a threshold of 60 pg/mL, the test correctly identified patients who would have complications with about 76% sensitivity and 79% specificity.
A second study found that BNP improved the accuracy of every established cardiac risk score when added to the evaluation. The specific cutoff values varied between studies, with one finding that a threshold around 149 ng/mL best predicted major adverse cardiac events and a threshold around 89 ng/mL best predicted one-year mortality. A third study in orthopedic patients found that those who experienced in-hospital cardiac events had dramatically higher preoperative BNP levels, with a median of 306 pg/mL versus 35 pg/mL in those without events.
The exact threshold that your surgical team uses will depend on the lab and the clinical context, but the principle is the same: a high BNP before surgery is a warning flag. It doesn’t necessarily mean the surgery can’t proceed, but it signals the need for more aggressive cardiac optimization beforehand, possibly including medication adjustments, fluid management changes, or a higher level of intraoperative monitoring. A low BNP, on the other hand, provides some reassurance even in patients with a heart failure diagnosis.
Anesthesia and What Happens in the Operating Room
The choice of anesthesia matters more for high-risk patients than for healthy ones. While the evidence base specifically comparing anesthesia types in heart failure hip replacement patients is limited, the general trend in high-risk orthopedic populations favors spinal (regional) anesthesia over general anesthesia. A study of patients with chronic lung disease undergoing hip surgery for fracture found that general anesthesia was an independent risk factor for 30-day death, unplanned intubation, and discharge to a facility rather than home. The mortality rate was 8.4% with general anesthesia versus 5.8% with spinal anesthesia in that population.
Heart failure patients share many of the same vulnerabilities as lung disease patients during surgery. General anesthesia typically requires a breathing tube and mechanical ventilation, which can increase pressure inside the chest and reduce blood return to an already struggling heart. Spinal anesthesia avoids this but causes blood pressure drops that also need careful management. Neither option is risk-free, and the choice depends on the individual patient’s cardiac function, anticoagulation status, and anatomy.
One specific intraoperative hazard that deserves mention is bone cement implantation syndrome. When surgeons use cement to fix the prosthetic components in place, pressurizing the cement can force fat, marrow, and air into the bloodstream, triggering a sudden drop in blood pressure, oxygen levels, and sometimes cardiac arrest. Patients with pre-existing heart or lung problems, pulmonary hypertension, and advanced age are at highest risk for this reaction. Surgical teams can take steps to reduce the danger, including using cement with a vent hole, washing the bone canal before insertion, and maintaining close hemodynamic monitoring during cementation. For some high-risk patients, surgeons may opt for an uncemented prosthesis to avoid the issue entirely.
Fluid management during surgery also requires special care. Too little fluid risks low blood pressure and organ injury; too much can push a failing heart into overload. Some centers use goal-directed fluid therapy, which involves real-time monitoring of how well the heart is ejecting blood with each beat and titrating fluids accordingly, rather than relying on fixed formulas.
Complications After Surgery
The postoperative period is where many of the excess risks for heart failure patients play out. Beyond the general surgical complications that affect all hip replacement patients, heart failure adds specific threats.
Acute heart failure exacerbation is one of the most common. A study of older adults with hip fractures found that the incidence of acute heart failure after surgery reached about 15%. The risk factors driving this included advanced age, cerebrovascular disease, liver cirrhosis, malnutrition, significant intraoperative blood loss, and low blood protein levels. Many of these overlap with factors already common in heart failure patients, which is why the perioperative team monitors fluid balance, hemoglobin, and nutrition closely.
Blood clots are another heightened concern. All hip replacement patients receive some form of clot prevention, typically blood-thinning medication started soon after surgery. Heart failure patients are at particular risk because reduced blood flow and prolonged immobility after surgery both promote clot formation. The standard protocols apply, but close attention to kidney function is needed since many anticoagulants are cleared by the kidneys, and heart failure patients already face elevated odds of acute kidney injury after surgery as noted in the complication data.
Infection risk also runs higher. The data show heart failure patients have increased rates of both deep surgical site infection and more widespread infections like sepsis and pneumonia. This likely reflects a combination of factors: poorer tissue oxygenation from reduced cardiac output, longer operative times, longer hospital stays with more exposure to hospital-acquired organisms, and the immune-dampening effects of chronic illness. Surgical teams typically maintain strict antibiotic protocols, but heart failure patients may need longer courses or closer wound surveillance.
What Recovery Looks Like
Recovery after hip replacement is slower and more complicated for heart failure patients. They’re more likely to be discharged to a rehabilitation facility rather than going home, and their hospital stays run longer. The rehabilitation itself needs to be adapted because exercise tolerance is limited by both the healing hip and the heart’s reduced capacity.
That said, successful rehabilitation is achievable. A documented case of a patient with both a total hip replacement and heart failure showed meaningful improvements in all measured outcomes after a nine-week program of home physical therapy, with sessions twice per week. The patient was able to meet ambulation goals and become independent in transfers. The key was integrating heart failure self-management into the rehab plan: monitoring daily weight for fluid shifts, adjusting activity levels based on symptoms like shortness of breath, and coordinating with cardiology throughout.
The rehabilitation timeline tends to be longer than for a typical hip replacement patient. Where a healthy patient might return to normal activities in 6 to 12 weeks, a heart failure patient should expect a more gradual progression. The physical therapist needs to balance pushing hard enough to restore hip strength and mobility against the risk of overloading the cardiovascular system. Heart rate monitoring, perceived exertion scales, and frequent check-ins with the cardiology team are standard practice for this population.
Do Heart Failure Patients Actually Feel Better Afterward?
This is the question that matters most to the person sitting in the orthopedic surgeon’s office. A hip replacement is only worth the risk if it leads to meaningful improvement in pain and function. The evidence here is cautiously encouraging. A recent study comparing patient-reported outcomes found that while heart failure patients had lower scores on hip function questionnaires at one year than non-heart-failure patients, a similar proportion in both groups achieved what researchers consider the minimum clinically important difference, meaning a noticeable improvement from where they started.
The picture isn’t entirely rosy, though. Greater proportions of heart failure patients fell short of thresholds for a “patient acceptable symptom state” in pain, physical function, and overall joint assessment. In plain terms, heart failure patients are more likely to feel better than before surgery but less likely to feel fully satisfied with their hip at one year. They also had higher rates of prolonged hospital stays, non-home discharge, and one-year mortality.
One interesting finding from the same data: the specific ejection fraction percentage did not predict healthcare utilization outcomes. A patient with an ejection fraction of 30% didn’t necessarily have worse surgical outcomes than one with an ejection fraction of 45%. Heart failure as a diagnosis mattered, but the severity measured by ejection fraction alone was not the defining variable. This suggests that other factors, including fitness level, nutrition, kidney function, and how well the heart failure is controlled by medication, may carry as much or more weight in determining who does well.
Who Should Not Have the Surgery?
There is no absolute ejection fraction cutoff below which hip replacement is universally refused. The decision is individualized. But there are situations where most surgical teams would advise against proceeding or at least delaying:
- Decompensated heart failure: If you’re currently in a flare with fluid overload, shortness of breath at rest, or recent hospitalization for heart failure, surgery should wait until the heart failure is stabilized.
- Severe pulmonary hypertension: High pressures in the lung arteries make anesthesia and cemented fixation particularly dangerous and may tip the risk-benefit ratio against surgery.
- Untreated or undiagnosed heart failure: Some patients arrive for hip replacement evaluation without knowing they have heart failure. Preoperative screening that turns up a new heart failure diagnosis should trigger a full cardiac workup before any surgical planning continues.
- Limited life expectancy from other causes: If advanced heart failure or other conditions give a patient a very short expected lifespan, the recovery burden of a major joint replacement may not be justified compared to less invasive pain management.
An important nuance here is the surgical setting. Heart failure has been identified as an independent risk factor for complications and the need for inpatient hospitalization after hip replacement, making outpatient or same-day surgery inappropriate for this population. If you have heart failure and are being evaluated at a surgical center that emphasizes outpatient joint replacement, make sure the team is prepared for an inpatient stay with cardiac monitoring and access to critical care if needed.
The Cardiology-Orthopedics Partnership
One of the clearest themes in the research is that outcomes improve when heart failure patients are managed by a coordinated team rather than falling through the gap between specialties. The cardiologist’s job is to optimize the heart before surgery: adjusting diuretics so fluid status is as close to ideal as possible, ensuring blood pressure medications are appropriate, checking that the heart rhythm is stable, and weighing in on whether any interventions like a pacemaker adjustment are needed. The orthopedic surgeon’s job is to assess whether the hip problem is severe enough that the expected functional gain justifies the added risk. The anesthesiologist’s job is to choose and execute the safest anesthetic plan given the cardiac limitations.
These decisions are better made together in advance than improvised on the day of surgery. If you have heart failure and are considering a hip replacement, ask specifically whether your cardiologist and surgeon have communicated directly about your case. A form letter saying “cleared for surgery” from a cardiologist who hasn’t seen recent echocardiogram results or BNP levels is not the same as a genuine collaborative assessment. The preoperative window is where the most important risk reduction happens, and it requires more than a checkbox.
For patients who decide to proceed, the practical preparation extends beyond medical optimization. Arranging for a rehabilitation facility stay rather than assuming you’ll go home, setting up home modifications like a raised toilet seat and grab bars for when you do return, and having a clear plan for medication management in the postoperative period all reduce the chance of complications that send you back to the hospital. Heart failure patients who undergo hip replacement with realistic expectations, thorough preparation, and coordinated care have the best chance of joining the group that reports meaningful improvement in pain and mobility after surgery.